Literature DB >> 9141430

Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion in rat liver.

Y Yamaguchi1, N Hisama, K Okajima, M Uchiba, K Murakami, Y Takahashi, S Yamada, K Mori, M Ogawa.   

Abstract

We investigated the role of anticoagulant in the ischemia/reperfusion injury of the liver, using activated protein C (APC), active human urinary thrombomodulin (UTM), and factor Xa blocked at the active site (DEGR-Xa). Liver ischemia was induced in male Wistar rats by occlusion of the portal vein with a microvascular clip for 30 minutes. Each anticoagulant was injected intravenously 10 minutes before clamping the portal vein. Serum concentrations of cytokine-induced neutrophil chemoattractant (CINC) were determined by enzyme-linked immunosorbent assay. The serum levels of CINC increased significantly following reperfusion, reaching a peak in 6 hours, and then decreasing gradually to control levels by 24 hours. CINC levels in rats pretreated with APC (500 U/kg), UTM (3,000 TMU/kg), or DEGR-Xa (10 mg/kg) peaked 3 hours following reperfusion and decreased rapidly to baseline level within 6 and 12 hours, respectively. These peak values were significantly lower than those observed in untreated rats (P < .01). Expression of CINC transcripts in liver tissue of untreated rats was evaluated by Northern blot analysis and peaked 3 hours following reperfusion. Pretreatment with these anticoagulants significantly decreased the expression of CINC messenger RNA transcripts as compared with untreated animals. Myeloperoxidase activity and the number of neutrophils accumulated into the liver 24 hours following ischemia/reperfusion were also significantly decreased in animals pretreated with these anticoagulants. In addition, correlations between the peak values of liver enzymes and serum CINC levels were found to be significant (P < .001). The inactive derivative of factor Xa, a selective inhibitor of thrombin generation, inhibited ischemia/reperfusion-induced increases in the serum concentration and messenger RNA transcript quantities of CINC. The inactive factor Xa also reduced hepatic accumulation of neutrophils after ischemia/reperfusion. These results indicate that the release of CINC is likely related to the hepatic microcirculation disturbance induced by microthrombotic occlusion following ischemia/reperfusion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9141430     DOI: 10.1002/hep.510250515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Soluble thrombomodulin protects ischemic kidneys.

Authors:  Asif A Sharfuddin; Ruben M Sandoval; David T Berg; Grant E McDougal; Silvia B Campos; Carrie L Phillips; Bryan E Jones; Akanksha Gupta; Brian W Grinnell; Bruce A Molitoris
Journal:  J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 10.121

2.  Role of activated protein C on wound healing process in left colonic anastomoses in the presence of intra-abdominal sepsis induced by cecal ligation and puncture: an experimental study in the rat.

Authors:  Zafer Teke; Suzan Sacar; Cigdem Yenisey; A Ozgur Atalay; Tulay Kavak; Ergun Erdem
Journal:  World J Surg       Date:  2008-08-05       Impact factor: 3.352

Review 3.  Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition.

Authors:  Johannes N Hoffmann; Brigitte Vollmar; Matthias W Laschke; Jan M Fertmann; Karl-Walter Jauch; Michael D Menger
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

4.  Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury.

Authors:  Akitoshi Matsuda; Naohisa Kuriyama; Hiroyuki Kato; Akihiro Tanemura; Yasuhiro Murata; Yoshinori Azumi; Masashi Kishiwada; Shugo Mizuno; Masanobu Usui; Hiroyuki Sakurai; Shuji Isaji
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

5.  The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice.

Authors:  Daisuke Noguchi; Naohisa Kuriyama; Taemi Hibi; Koki Maeda; Toru Shinkai; Kazuyuki Gyoten; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Akihiro Tanemura; Yasuhiro Murata; Masashi Kishiwada; Hiroyuki Sakurai; Shugo Mizuno
Journal:  Liver Transpl       Date:  2020-12-09       Impact factor: 5.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.